Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3013)
All Articles published online
|
Jun 21, 2006 (publication date) through Feb 3, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Okuse C, Yotsuyanagi H, Nagase Y, Kobayashi Y, Yasuda K, Koike K, Iino S, Suzuki M, Itoh F. Risk factors for retinopathy associated with interferon α-2b and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(23): 3756-3759 [PMID: 16773695 DOI: 10.3748/wjg.v12.i23.3756] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i23/3756.htm |
| Number | Citing Articles |
| 1 |
Junaid Siddiqui, Jacinthe Rouleau, Andrew G Lee, Yutaka Sato, Michael D Voigt. Bilateral Optic Neuritis in Acute Hepatitis C. Journal of Neuro-Ophthalmology 2009; 29(2): 128 doi: 10.1097/WNO.0b013e3181989783
|
| 2 |
C. Burgueño-Montañés, R. Pérez-Álvarez. Retinopatía asociada a interferón pegilado y ribavirina en pacientes con hepatitis C. Archivos de la Sociedad Española de Oftalmología 2011; 86(6): 193 doi: 10.1016/j.oftal.2010.12.015
|
| 3 |
Masaaki Watanabe, Sumie Ogasawara, Akihiko Takahashi, Juichi Takada, Yoshiaki Tanaka, Yusuke Okuwaki, Tsutomu Minamino, Hisashi Hidaka, Takahide Nakazawa, Akitaka Shibuya, Wasaburo Koizumi. Branch retinal artery occlusion and central retinal vein occlusion associated with pegylated interferon plus ribavirin combination therapy for chronic hepatitis C. Cutaneous and Ocular Toxicology 2012; 31(3): 253 doi: 10.3109/15569527.2011.641197
|
| 4 |
Mohamed Samy Abd Elaziz, Ali Saad Eldeen Nada, Saber Hamid ElSayed, Ghada Salah Nasr, Adel Galal Zaky. Ocular comorbidities with direct-acting antiviral treatment for chronic hepatitis C virus (HCV) patients. International Ophthalmology 2020; 40(5): 1245 doi: 10.1007/s10792-020-01290-y
|
| 5 |
Michael R Narkewicz, Philip Rosenthal, Kathleen B Schwarz, Arlene Drack, Todd Margolis, Michael X Repka. Ophthalmologic Complications in Children With Chronic Hepatitis C Treated With Pegylated Interferon. Journal of Pediatric Gastroenterology and Nutrition 2010; 51(2): 183 doi: 10.1097/MPG.0b013e3181b99cf0
|
| 6 |
A. Sauer, P. Lenoble, P. Bader, C. Speeg-Schatz, T. Bourcier, X. Nasica. Complications ophtalmologiques du traitement de l’hépatite C. Journal Français d'Ophtalmologie 2007; 30(7): 746.e1 doi: 10.1016/S0181-5512(07)91366-2
|
| 7 |
Kayoko Sugawara, Mie Inao, Nobuaki Nakayama, Satoshi Mochida. Telaprevir-induced, but not pegylated interferon-associated, retinopathy as a noteworthy adverse effect during triple antiviral therapy in patients with chronic hepatitis C. Journal of Gastroenterology 2014; 49(2): 363 doi: 10.1007/s00535-013-0889-8
|
| 8 |
Yasser M. Fouad, Hanaa Khalaf, Hala Ibraheem, Heba Rady, Amal K. Helmy. Incidence and risk factors of retinopathy in Egyptian patients with chronic hepatitis C virus treated with pegylated interferon plus ribavirin. International Journal of Infectious Diseases 2012; 16(1): e67 doi: 10.1016/j.ijid.2011.09.022
|
| 9 |
Nasser Mousa, Tarek Besheer, Yahia Gad, Amal Elbendary, Tharwat Mokbel, Azza Abdel-Aziz. Is Combination Therapy Interferon and Ribavirin in Patients with Chronic Hepatitis C Infection Toxic for Eyes?. Journal of Ocular Pharmacology and Therapeutics 2013; 29(3): 345 doi: 10.1089/jop.2012.0169
|
| 10 |
Hee Young Kang, Ji Won Lim, Min Chul Shin. Pegylated Interferon Associated Retinopathy in Chronic Hepatitis Patients. Journal of the Korean Ophthalmological Society 2009; 50(3): 383 doi: 10.3341/jkos.2009.50.3.383
|
| 11 |
Chiaki Okuse, Hiroki Ikeda, Yoshihiko Nagase, Norie Yamada, Masaru Okamoto, Minoru Kobayashi, Hideaki Takahashi, Yoshiki Katakura, Kotarou Matsunaga, Nobuyuki Matsumoto, Hiroshi Yotsuyanagi, Kazuhiko Koike, Shiro Iino, Michihiro Suzuki, Fumio Itoh. Frequency and risk factors for retinopathy associated with pegylated interferon α2b and ribavirin combination therapy in patients with chronic hepatitis C. Kanzo 2008; 49(11): 520 doi: 10.2957/kanzo.49.520
|
| 12 |
Hee Young Kang, Min Chul Shin. Pegylated Interferon-Associated Severe Retinopathy in a Patient with Chronic Hepatitis. Korean Journal of Ophthalmology 2012; 26(2): 147 doi: 10.3341/kjo.2012.26.2.147
|
| 13 |
A. Viennet, F. Glatre, F. Bacin. Rétinopathie à interferon alpha 2b et ribavirine chez un patient atteint d’une hépatite C chronique. Journal Français d'Ophtalmologie 2009; 32(7): 505 doi: 10.1016/j.jfo.2009.04.007
|
| 14 |
Shih-Yi Lin, Cheng-Li Lin, Shu-Woei Ju, I-Kuan Wang, Cheng-Chieh Lin, Chih-Hsueh Lin, Wu-Huei Hsu, Ji-An Liang, Tatsuo Kanda. Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study. PLOS ONE 2017; 12(3): e0173125 doi: 10.1371/journal.pone.0173125
|
| 15 |
C. Burgueño-Montañés, R. Pérez-Álvarez. Pegylated interferon and ribavirin associated retinopathy in patients with hepatitis C. Archivos de la Sociedad Española de Oftalmología (English Edition) 2011; 86(6): 193 doi: 10.1016/j.oftale.2010.12.003
|
| 16 |
Supriya Arora, Thamolwan Surakiatchanukul, Tarun Arora, Marie Helene Errera, Hitesh Agrawal, Marco Lupidi, Jay Chhablani. Retinal toxicities of systemic anticancer drugs. Survey of Ophthalmology 2022; 67(1): 97 doi: 10.1016/j.survophthal.2021.05.007
|
| 17 |
A. Raza, S. Mittal, G. K. Sood. Interferon‐associated retinopathy during the treatment of chronic hepatitis C: a systematic review. Journal of Viral Hepatitis 2013; 20(9): 593 doi: 10.1111/jvh.12135
|
| 18 |
KASL clinical practice guidelines: Management of Hepatitis C. Clinical and Molecular Hepatology 2014; 20(2): 89 doi: 10.3350/cmh.2014.20.2.89
|
| 19 |
KASL clinical practice guidelines: management of hepatitis C. Clinical and Molecular Hepatology 2016; 22(1): 76 doi: 10.3350/cmh.2016.22.1.76
|
| 20 |
Meghan Berkenstock, Shaivi Patel, Jessica Ackert. A Drop in Hemoglobin as An Association with Pegylated Interferon Retinopathy. Journal of Current Ophthalmology 2020; 32(2): 195 doi: 10.4103/JOCO.JOCO_103_20
|
| 21 |
Reid Longmuir, Andrew G. Lee, Jacinthe Rouleau. Cotton Wool Spots Associated with Interferon Beta-1 Alpha Therapy. Seminars in Ophthalmology 2007; 22(1): 49 doi: 10.1080/08820530601182725
|
| 22 |
S. Trad, C. Bonnet, D. Monnet. Uvéite médicamenteuse et effets indésirables des médicaments en ophtalmologie. La Revue de Médecine Interne 2018; 39(9): 699 doi: 10.1016/j.revmed.2018.02.017
|
| 23 |
Chien‐Hsiung Lai, Yao‐Hsu Yang, Pau‐Chung Chen, Ying‐Chi King, Chia‐Yen Liu. Retinal vascular complications associated with interferon‐ribavirin therapy for chronic hepatitis C: A population‐based study. Pharmacoepidemiology and Drug Safety 2018; 27(2): 191 doi: 10.1002/pds.4363
|
| 24 |
Joon Hyung Yeo, Kyoung Woo Kim, Jae Chan Kim. Mooren’s ulcerative keratitis after systemic pegylated interferon alpha2a in chronic hepatitis C. Canadian Journal of Ophthalmology 2017; 52(5): e163 doi: 10.1016/j.jcjo.2017.03.018
|
| 25 |
Shelly Adams, Mark Ostermeier. Retinopathy associated with pegylated interferon and ribavirin treatment for chronic hepatitis C. Optometry - Journal of the American Optometric Association 2010; 81(11): 580 doi: 10.1016/j.optm.2010.04.094
|
| 26 |
Mark Hull, Stephen Shafran, Alex Wong, Alice Tseng, Pierre Giguère, Lisa Barrett, Shariq Haider, Brian Conway, Marina Klein, Curtis Cooper. CIHR Canadian HIV Trials Network Coinfection and Concurrent Diseases Core Research Group: 2016 Updated Canadian HIV/Hepatitis C Adult Guidelines for Management and Treatment. Canadian Journal of Infectious Diseases and Medical Microbiology 2016; 2016: 1 doi: 10.1155/2016/4385643
|
| 27 |
Zubir S. Rentiya, Matthew Wells, Junun Bae, Kuan-Jen Chen, An-Ning Chao, Nicholas Turgeon, Syed M. Shah, Mostafa Hanout. Interferon-α-induced retinopathy in chronic hepatitis C treatment: summary, considerations, and recommendations. Graefe's Archive for Clinical and Experimental Ophthalmology 2019; 257(3): 447 doi: 10.1007/s00417-018-04209-7
|
| 28 |
J. D. PANETTA, N. GILANI. Interferon‐induced retinopathy and its risk in patients with diabetes and hypertension undergoing treatment for chronic hepatitis C virus infection. Alimentary Pharmacology & Therapeutics 2009; 30(6): 597 doi: 10.1111/j.1365-2036.2009.04071.x
|
| 29 |
Nicolas Bourgeois, François Chavant, Claire Lafay-Chebassier, Nicolas Leveziel, Marie-Christine Pérault-Pochat. Atteintes rétiniennes iatrogènes : étude cas/non cas dans la banque nationale de pharmacovigilance. Therapies 2016; 71(4): 365 doi: 10.1016/j.therap.2016.02.024
|
| 30 |
G. Ngatcha, F. Rouibaa, S. Majdouli, A. Arouah, A. Feqhi, A. Oubaaz. Rétinopathie à interferon pégylé alpha 2a et ribavirine au cours d’une hépatite virale C chronique. Journal Africain d'Hépato-Gastroentérologie 2013; 7(1): 53 doi: 10.1007/s12157-012-0444-x
|
| 31 |
Nilesh Mehta, Uma K. Murthy, Vivek Kaul, Samuel Alpert, Gerald Abruzzese, Charles Teitelbaum. Outcome of Retinopathy in Chronic Hepatitis C Patients Treated with Peginterferon and Ribavirin. Digestive Diseases and Sciences 2010; 55(2): 452 doi: 10.1007/s10620-009-0721-8
|
| 32 |
Menelaos Kanakis, Petros Petrou, Giota Lourida, Ilias Georgalas. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective. Survey of Ophthalmology 2022; 67(2): 388 doi: 10.1016/j.survophthal.2021.05.013
|
| 33 |
Masako Murata, Yuu Tamura, Masaya Ohsawa, Takao Hirano, Toshihiko Matsuo, Toshinori Murata. Central retinal vein occlusion in hypertensive patients with chronic hepatitis C treated with interferon α and ribavirin. Japanese Journal of Ophthalmology 2008; 52(6): 511 doi: 10.1007/s10384-008-0585-z
|
| 34 |
Fatih Selcukbiricik, Deniz Tural, Tuba Elif Senel, Ahmet Sarıca, Ozlem Soyluk, Suheyla Serdengecti. Bilateral Ischemic Optic Neuropathy Developed under Interferon Therapy. Case Reports in Ophthalmological Medicine 2012; 2012: 1 doi: 10.1155/2012/102739
|
| 35 |
Shijie Lan, Zhihua Cui, Qiliang Yin, Zhigang Liu, Lingling Liang, Hua He, Hesong Liu, Zhen Guo, Yingying Yu, Di Wu. Prospective study of clinical characteristics of melanoma patients with retinopathy caused by a high-dose interferon α-2b. Melanoma Research 2021; 31(6): 550 doi: 10.1097/CMR.0000000000000769
|
| 36 |
Ligita Jancoriene, Dovile Norvydaite, Saulius Galgauskas, Evelina Balciunaite. Transient Visual Loss in a Hepatitis C Patient Treated With Pegylated Interferon Alfa-2a and Ribavirin. Hepatitis Monthly 2014; 14(2) doi: 10.5812/hepatmon.15124
|
| 37 |
Bohdan M. Patskan, Valerii D. Beliayev, Kateryna V. Bora, Nataliia V. Bondarenko. A case of successful treatment of a rare retinal disease presented by interferon-induced retinopathy. Wiadomości Lekarskie 2024; 77(3): 491 doi: 10.36740/WLek202403117
|
| 38 |
Stela Vujosevic, Diego Tempesta, Franco Noventa, Edoardo Midena, Giada Sebastiani. Pegylated interferon-associated retinopathy is frequent in hepatitis C virus patients with hypertension and justifies ophthalmologic screening. Hepatology 2012; 56(2): 455 doi: 10.1002/hep.25654
|
| 39 |
Maysa F. Salem, Manal I. El-Bermawy. Effect of interferon, ribavirin, and a combination of both on the retina of adult male albino rats. The Egyptian Journal of Histology 2015; 38(3): 558 doi: 10.1097/01.EHX.0000470829.83093.5e
|